A purchase and sale agreement (SPA) is the contract that closes an M&A deal, and its four economic levers — representations and warranties, indemnification, escrow, and earnouts — determine how much of the headline price a seller actually keeps and how much risk a buyer carries after signing. Understanding SPA structure means understanding where cash gets held back, when it gets released, and which post-closing surprises can claw money back. The reps, warranties, escrow, and earnout provisions are where 80% of the negotiation happens after the LOI is signed.
The Five Economic Levers Inside a Purchase and Sale Agreement
A purchase and sale agreement structure looks like a legal document, but read it as a cash-flow waterfall. Every clause moves money between buyer and seller across a time axis. The five levers that matter economically are:
- Purchase price and consideration mix — cash, stock, rollover equity, and seller notes.
- Purchase price adjustments (PPA) — working capital, cash, debt, and transaction expense true-ups at closing.
- Representations and warranties — the seller's factual statements about the business, breach of which triggers indemnity claims.
- Escrow and RWI — the mechanism that funds recovery for indemnity claims and PPA disputes.
- Earnouts — contingent post-closing payments tied to future performance.
The SRS Acquiom 2025 Deal Terms Study — which analyzed more than 2,200 private-target acquisitions closed between 2019 and 2024 with an aggregate deal value of $505 billion — found that over three-quarters of these deals included a special-purpose escrow for the PPA alone, separate from any indemnity escrow. That single data point tells you the PPA true-up is not administrative housekeeping; it is a live negotiation.
Takeaway: Before you negotiate a single word of the SPA, map the five levers on one page and mark which ones your counterparty cares about most. That map is your trade sheet for the rest of the deal.
Reps and Warranties: What Actually Gets Negotiated
Representations and warranties are the seller's contractual statements about the target company — that the financial statements are accurate, that all material contracts are disclosed, that there is no undisclosed litigation, that IP is owned and not infringing, that taxes are paid, and dozens more. If any of them turns out to be false, the buyer can sue for indemnification.
Fundamental vs. General Reps
Not all reps are created equal. The market splits them into two buckets:
- Fundamental reps — organization, authority, capitalization, title to shares, and sometimes taxes. These typically survive indefinitely (or to the statute of limitations) and are capped at the full purchase price.
- General reps — everything else. These typically survive 12 to 24 months post-closing and are capped at a fraction of the purchase price (often 10% without RWI, or 0.5% with RWI, per SRS Acquiom's 2025 data on general indemnification escrow medians).
Materiality Scrapes and Sandbagging
Two clauses do most of the heavy lifting in indemnity math:
- Materiality scrape — a provision that reads "materiality" out of the reps for damage calculation purposes. A seller-favorable draft has no scrape. A buyer-favorable draft scrapes materiality both for breach determination and damages.
- Pro-sandbagging clause — allows the buyer to bring an indemnity claim even if it knew the rep was inaccurate before closing. The SRS Acquiom 2025 study noted that RWI-inclusive deals show a lower likelihood of pro-sandbagging provisions, because insurers underwrite around them.
The Microsoft–Activision Blizzard merger agreement filed in January 2022 is a useful public reference. Section 3.19 of that agreement carried a bespoke "No Allegations of Sexual Harassment, Sexual Misconduct or Retaliation" rep — a reminder that reps are custom instruments that reflect deal-specific diligence findings, not generic boilerplate.
Takeaway: When you get the first draft SPA, tag every rep as fundamental or general, and confirm survival period, cap, and scrape language for each bucket before you argue price.
Escrow Structures and RWI: How the Money Is Actually Held Back
Historically, buyers held back 10% to 15% of the purchase price in a general indemnity escrow for 12 to 24 months. That is now a minority pattern. Representations and warranties insurance (RWI) has moved the market.
The 2025 ABA Private Target M&A Deal Points Study, released in December 2025, reported that 63% of deals in the study period referenced RWI, up from 55% in the 2023 study. SRS Acquiom's 2025 data put RWI presence at 42% of 2024 deals — the two studies use different denominators, but the direction is the same: RWI is now standard on middle-market and above.
With RWI in place, the escrow architecture typically looks like this:
- PPA escrow — 0.25% to 1% of deal value, released 60 to 120 days post-closing after the working capital true-up. SRS Acquiom found this in 88% of RWI-identified deals.
- Indemnity retention — the RWI policy's self-insured retention, typically 0.5% to 1% of enterprise value, funded via a small escrow that sits alongside the RWI tower.
- Special-purpose escrows — for known risks (pending litigation, a disputed tax position, a specific environmental exposure). SRS Acquiom found roughly three in ten deals carried one of these.
The pricing has shifted. Marsh's 2025 Global Transactional Risk Insurance Report, reported by CFO Dive in April 2025, found that average RWI premiums rose 16% in North America year-over-year, reversing a post-pandemic decline. Craig Schioppo, Marsh's global head of transactional risk, attributed the move to claim activity. Rate-on-line (premium as a % of coverage limit) is bumping against 3% floors at some carriers, though competition among Marsh, Aon, WTW, and Lockton keeps quotes tiered.
Takeaway: For deals above $30M enterprise value, get RWI quotes before you finalize the LOI. The premium — typically 2.5% to 4% of the coverage limit — is often cheaper for the seller than a 10% escrow tying up capital for 18 months.
Earnouts: The Highest-Litigation Clause in an SPA
Earnouts bridge valuation gaps by tying part of the price to post-closing performance. They are also, empirically, where deals go to court. The SRS Acquiom 2025 study found that 68% of deals with earnouts include multiple metrics, that performance periods are trending shorter (fewer deals extending past four years), and that earnouts pay only about 21 cents on the dollar of the maximum available across all deals with earnouts.
That last number — 21 cents — is the one every seller misreads. The headline "up to $50M earnout" typically converts to $10.5M of actual cash. Design the earnout as if that is the expected outcome, not a downside scenario.
Litigation examples show what happens when the mechanic is loose:
- Fortis Advisors v. Johnson & Johnson (Auris Health). After a 10-day Delaware Chancery trial with roughly 70 depositions and nine experts, the former Auris shareholders won an $811 million damages award against J&J in 2024 — the largest earnout-related damages award in Delaware history, according to plaintiffs' counsel Selendy Gay. The dispute turned on whether J&J had used commercially reasonable efforts to hit the earnout milestones for the acquired robotic-surgery business.
- UMB Bank as trustee for Celgene CVR holders v. Bristol-Myers Squibb. Contingent value right (CVR) holders from the 2019 Celgene acquisition sought nearly $7 billion in damages, alleging BMS failed to timely secure regulatory approval of three cancer therapies tied to the CVR payout.
- Fortis Advisors v. Stillfront (Del. Supreme Court, February 2026). The court held that an ADR clause routing "calculation of the earnout amount" to an independent accountant also swept in claims of bad-faith operational-covenant breach — a warning that earnout dispute-resolution language is read broadly.
Skadden's December 2024 "Earnout Eruption" analysis flagged the surge in Delaware "best efforts" litigation as the dominant post-closing dispute category. The lesson: an earnout without specific, measurable operational covenants (headcount, R&D spend, sales territory, product roadmap) invites an implied-covenant claim.
Takeaway: If you must use an earnout, write the operational covenants with the specificity of an operating plan. "Commercially reasonable efforts" is where deals get sued; "maintain minimum R&D spend of $12M per year and retain the CTO" is where they get paid.
Reading the Market: The Buyer/Seller Trade Matrix
The 2025 deal points studies show a market that has drifted seller-favorable on some clauses and buyer-favorable on others. The trades to watch:
- Escrow size — seller-favorable. Median general indemnity escrow of 0.5% (with RWI) is dramatically lower than the historic 10%.
- Materiality scrapes — mixed. RWI deals show a lower likelihood of a full scrape, per SRS Acquiom.
- Non-reliance clauses — buyer-favorable in some senses, seller-favorable in others. RWI-inclusive deals show increased use of "no other representations" and "non-reliance" language, which limits fraud claims outside the four corners of the SPA.
- Indemnity for "alleged" breaches — buyer-favorable. The 2025 ABA study reported this rose from 17% to 27%, driven by RWI carriers wanting flexibility to fund defense on unproven claims.
- Fraud carve-outs — buyer-favorable. The 2025 ABA study specifically tracks how often fraud is included as a stand-alone indemnity, which survives caps and RWI exclusions.
Takeaway: Print the SRS Acquiom and ABA study data next to your draft SPA. When your counsel says a term is "market," ask which study, which vintage, and which deal-size band.
How to Structure Your Own SPA Before You Sign the LOI
Most of the SPA is pre-determined by the LOI. Fight the fight early. A practical step-by-step:
- Model the cash waterfall at LOI stage. Build an Excel spreadsheet model that shows purchase price minus PPA escrow minus indemnity escrow minus expected earnout (at 21% of max), timed month-by-month. This is the number the seller actually receives.
- Get RWI quotes before signing the LOI. Two or three broker quotes take 5–10 business days. Knowing your RWI premium and retention lets you negotiate the escrow structure with real numbers.
- Define the earnout metric with a formula, not an adjective. "Revenue" needs a GAAP definition, a customer-recognition rule, and a treatment for intercompany transactions. Attach an example calculation as a schedule.
- Draft the operational covenants as a schedule to the SPA. List every commitment the buyer makes about how the target will be run during the earnout period. Reference the Auris and Stillfront cases in your negotiation to explain why.
- Pick a dispute-resolution architecture. Working-capital true-ups go to an independent accountant. Earnout calculation disputes should split "arithmetic" (accountant) from "covenant breach" (arbitration or Delaware Chancery) — the Stillfront ruling shows how easily one path swallows the other.
- Pre-negotiate the disclosure schedule format. Reps are read against disclosure schedules. Agreeing early on schedule structure prevents a two-week fire drill before signing.
Takeaway: The SPA is won or lost in the two weeks after the LOI is signed. A ready-made SPA template, indemnification matrix, and earnout model turn those two weeks into a checklist rather than a scramble.
The Compounding Value of a Ready-Made Template
A first-time seller who tries to draft an SPA from scratch spends 60–100 hours of legal time reinventing structures that have been market-tested by SRS Acquiom, the ABA, Marsh, and every major law firm. A buyer who negotiates a first M&A deal without an earnout playbook signs the loose "commercially reasonable efforts" language that fed the Auris and Celgene disputes. A ready-made purchase and sale agreement template, complete with an indemnification matrix, RWI-vs-escrow comparison model, and earnout mechanics schedule, cuts that curve by 80% — and, more importantly, means the terms you sign reflect current market data rather than a decade-old form. That is what compounds across deals: the discipline of starting from a structure that already knows where the money moves.
Sources
- SRS Acquiom, "M&A Deal Terms Study 2025"
- SRS Acquiom, "RWI findings from the 2025 M&A Deal Terms Study"
- ABA Business Law Today, "Announcing the ABA's 2025 Private Target Mergers & Acquisitions Deal Points Study," December 2025
- Wagner Hicks PLLC, "The New Normal in Private M&A: Key Takeaways from the 2025 ABA Deal Points Study"
- CFO Dive, "Deal insurance gets pricier after years of decline: Marsh," 2025
- Selendy Gay PLLC, Fortis Advisors v. Johnson & Johnson (Auris Health) case summary
- Skadden, Arps, Slate, Meagher & Flom, "Earnout Eruption: Delaware Courts Interpret 'Best Efforts' Clauses," December 2024
- Harvard Law School Forum on Corporate Governance, "Delaware Supreme Court Guidance on ADR Provisions to Resolve Earnout Disputes—Stillfront," March 2026
- DealLawyers.com, "Poking Around the Microsoft-Activision Blizzard Merger Agreement," January 2022
Related: Browse all Investment Banking & M&A Templates on ModelStack.
Get started with a free template
Download our free Unit Economics Calculator — no signup required.